• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

International Alliance of ALS/MND Associations

  • Members' Login
  • Contact
  • Join the Alliance
  • Donate
  • Understanding ALS/MND
    • What is ALS/MND
    • Genetics
    • Navigating the Community
  • Find a Member Association
  • Support for PALS & CALS
    • Fundamental Rights for People with ALS/MND and Caregivers
    • Research
      • Voice Preservation
      • Open Science
        • Open Label Extension
      • Expanded Access
      • Understanding ALS/MND Research
      • Improving Regulatory Pathways
      • Right to Try
      • US FDA Orphan Drug Designation
      • Unproven (Off-Label) Treatments
    • Advocacy
      • Advocacy Toolkit
      • Emergency Preparedness Toolkit
      • Equitable Access to Therapies
      • Recommendations for Trial Sponsors
    • Clinical Care
      • Genetic Counselling & Testing
      • Mental Health Support
      • Nursing and Symptom Management
      • Nutrition and Swallowing
      • Occupational Therapy and Activities of Daily Living
      • Physiotherapy and Mobility
      • Respiratory Care
      • Speech Therapy and Communication
      • Support for Family & Caregivers
      • Technology
      • Global Clinic Locator
    • Drugs in Development
      • AB Science – Masitinib
      • BrainStorm Cell Therapeutics – NurOwn
      • Clene Nanomedicine – CNM-Au8
      • ILB – Tikomed
      • Kadimastem – AstroRx
      • Mitsubishi Tanabe Pharma America – Oral Edaravone
      • Neuronata-R/Lenzumestrocel
      • NeuroSense – PrimeC
      • Neuvivo – NP001
      • Prilenia Therapeutics – Pridopidine
      • SOD1 Therapies & Trials
      • SPG302
      • T Regulatory Cell Therapies
      • Ulefnersen – Ionis Pharmaceuticals
    • Approved Drugs
      • Nuedexta
      • Radicava/Edaravone
      • Riluzole/Tiglutik
      • Rozebalamin/Methylcobalamin
      • Tofersen/Qalsody
    • Drugs No Longer in Development
      • Amylyx – AMX0035
      • Collaborative Medicinal Development – CuATSM
      • Cytokinetics – Reldesemtiv
      • Orphazyme – Arimoclomol
      • TUDCA Trial
  • Support for Health Professionals
    • Breaking the News in ALS/MND
  • Events/Programs
    • Calendar of Events/Programs
    • Global Day Calendar
    • Alliance Meeting
    • Allied Professionals Forum
    • “Day in the Life Of” Suite
    • Alliance Webinars
    • ALS/MND Connect
    • March of Faces
    • Patient Fellows Program
    • Alliance Fellows
    • SEED Grant Program
    • International Symposium
  • About
    • Who We Are
    • ALS/MND Health Literacy Map
    • Board of Trustees
    • Advisory Councils/Committees
      • Scientific Advisory Council
      • PALS and CALS Advisory Council
      • Advocacy and Public Policy Forum
      • Research Directors Forum
      • Governance Committee
      • Finance Committee
    • Staff
    • History
    • Archives
      • Newsletters
      • Meetings
    • Awards
      • Forbes Norris Award
      • Humanitarian Award
      • Allied Health Professional Award
      • Student Innovation Award
  • Members
    • Member Registration
    • Forgot Password

Forum Guidelines

International Alliance of ALS/MND Associations › Forums › Member Forum › Forum Guidelines

  • This topic has 0 replies, 1 voice, and was last updated 9 years, 10 months ago by Admin.
Viewing 1 post (of 1 total)
  • Author
    Posts
  • August 15, 2016 at 9:48 am #2059
    Admin
    Keymaster

      While writing on the forum, we expect all members to treat one another with respect, even if we may disagree. Our Executive Director will moderate the forum to the best of her ability. Please alert Cathy (alliance@als-mnd.org) if anyone is misusing the forum. We hope this is a wonderful resource for all of our members.

      • This topic was modified 6 years, 3 months ago by International Alliance.
      • This topic was modified 6 years, 3 months ago by Admin.
    • Author
      Posts
    Viewing 1 post (of 1 total)
    • You must be logged in to reply to this topic.
    Log In

    Primary Sidebar

    • Fabio Carvalho, Brazil

      Fabio Carvalho, Brazil

    • Valdomiro Xavier Honório, Brazil

      Valdomiro Xavier Honório, Brazil

    • Jette Odgaard Villemoes, Denmark

      Jette Odgaard Villemoes, Denmark

    • Willi Klein, UK

      Willi Klein, UK

    • Steve Gallagher, Canada

      Steve Gallagher, Canada
      Picture1

    • Mike Cels, Canada

      Mike Cels, Canada

    • Xian-Zhang Niu, China

      Xian-Zhang Niu, China

    • David Watson, Scotland

      David Watson, Scotland

    • Kris Van Reusel, Belgium

      Kris Van Reusel, Belgium

    • Frank Bos, Netherlands

      Frank Bos, Netherlands

    • Graham Johnson, Australia

      Graham Johnson, Australia

    • Mark Miller, UK

      Mark Miller, UK

    • Jon Newsome, USA

      Jon Newsome, USA

    • Bob Spurrier, USA

      Bob Spurrier, USA

    • Den Haag, Netherlands

      Den Haag, Netherlands

    • Maria Santos Garcia Tellez, Mexico

      Maria Santos Garcia Tellez, Mexico

    • Mona H. Bahus and Camilla Knoff Glomstad, Norway

      Mona H. Bahus and Camilla Knoff Glomstad, Norway

    • David Hall, USA

      David Hall, USA

    • Joy Blakeley, Australia

      Joy Blakeley, Australia

    • Andrietta, Italy

      Andrietta, Italy
      Andrietta

    • Len Johnrose, England

      Len Johnrose, England

    • Feng Gin Sun, China

      Feng Gin Sun, China

    • Rolf Mauch, Switzerland

      Rolf Mauch, Switzerland

    • Anita Forte, USA

      Anita Forte, USA

    • John Sweeney, USA

      John Sweeney, USA

    • Michael Lee, Australia

      Michael Lee, Australia

    • Peng Yi-Wen, Taiwan

      Peng Yi-Wen, Taiwan

    • Dorette Lüdi, Switzerland

      Dorette Lüdi, Switzerland

    • Ywan Dierick, Belgium

      Ywan Dierick, Belgium

    • Ismail Gokcek, Turkey

      Ismail Gokcek, Turkey
      ismail_gokcek_alsmnd_tr

    • H. Todd Kelly, USA

      H. Todd Kelly, USA

    • Conny van der Meijden, Netherlands

      Conny van der Meijden, Netherlands

    • Jay Epstein, USA

      Jay Epstein, USA

    • Sam Hayden-Harler, UK

      Sam Hayden-Harler, UK

    • Gudjon Sigurdsson, Iceland

      Gudjon Sigurdsson, Iceland

    • Steve Lufkin, USA

      Steve Lufkin, USA
      IMG_3993

    • Shay Rishoni, Israel

      Shay Rishoni, Israel

    • Ann Nicol, USA

      Ann Nicol, USA

    • Jose Rivero Muñoz, Mexico

      Jose Rivero Muñoz, Mexico

    • Rudiger Hanemann, Germany

      Rudiger Hanemann, Germany

    • Fabrice Kamp, Germany

      Fabrice Kamp, Germany

    • Dick Dayton, USA

      Dick Dayton, USA

    • Animesh Kumar, India

      Animesh Kumar, India

    • Antonio Ventriglia, Belgium

      Antonio Ventriglia, Belgium

    • Mary Thomas, Australia

      Mary Thomas, Australia

    • Camilla Heiberg Freiberg, Denmark

      Camilla Heiberg Freiberg, Denmark

    • Glen Victor Peters, Australia

      Glen Victor Peters, Australia

    • Wendy Hendrickson, USA

      Wendy Hendrickson, USA

    • Seckin McGuirk, England

      Seckin McGuirk, England

    • Imelda Arenas, Colombia

      Imelda Arenas, Colombia

    Learn more about the March of Faces

    Footer

    Stay connected to the global ALS/MND community.

    Subscribe to receive our newsletter and updates on how to get involved across the Alliance network.

     
    This field is for validation purposes and should be left unchanged.
    • Email
    • Facebook
    • LinkedIn
    • Twitter
    • YouTube
    Return to top of page

    Contact | Disclaimer | Privacy Notice & Cookies | Sitemap

    Copyright © 2026 The International Alliance of ALS/MND Associations. All rights reserved.


    Registered in England: Charity Number 1079504 · Site built by graphics.coop · Powered by WordPress · Members' login